A Whole New You

MarketsFOXBusiness

Image 1 of 9

San Diego-based Organovo is engineering human tissue using a 3-D ‘bioprinter’. The process involves printing cells onto a gel matrix that holds the cells in position for 24 hours until the cells fuse together. The company is currently creating blood vessels and hopes to move into clinical trials in 3 to 4 years. WATCH: Regenerative Medicine: A Growing Market

Continue Reading Below